Emergency management of meningococcal disease

Archives of Disease in Childhood

Volumn 80, Issue 3, 1999, Pages 290-296

  Pollard, A J ^a   Britto, J ^a   Nadel, S ^a   DeMunter, C ^a   Habibi, P ^a   Levin, M ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; PENICILLIN DERIVATIVE; STEROID;

ANTIBIOTIC SENSITIVITY; ASSISTED CIRCULATION; CEREBROSPINAL FLUID ANALYSIS; DISEASE SEVERITY; EARLY DIAGNOSIS; EMERGENCY TREATMENT; HEALTH CARE POLICY; INTENSIVE CARE; INTRACRANIAL PRESSURE; MENINGOCOCCOSIS; MORTALITY; NEISSERIA MENINGITIDIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESUSCITATION; REVIEW; SHOCK; TREATMENT INDICATION;

EID: 0033015483     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.80.3.290     Document Type: Review

References (60)

1. 1 Platt M. Child health statistical review. Arch Dis Child 1997;77:542-8.
2. 2 Anon. 1995 Communicable disease statistics. London: Office of National Statistics, 1997.
3. 3 CDSC. Notifications of infectious diseases. Commun Dis Rep CDR Wkly 1998;8(2):17-20.
4. 4 Ramsay M, Kaczmarski E, Rush M, Mallard R, Farrington P, White J. Changing patterns of case ascertainment and trends in meningococcal disease in England and Wales. Commun Dis Rep CDR Rev 1997;7(4):R49-54.
5. 5 Havens PL, Garland JS, Brook MM, Dewitz BA, Stremski ES, Troshynski TJ. Trends in mortality in children hospitalized with meningococcal infections, 1957 to 1987. Pediatr Infect Dis J 1989;8:8-11.
6. 6 Kirsch EA, Barton RP, Kitchen L, Giroir BP. Pathophysiology, treatment and outcome of meningococcemia: a review and recent experience. Pediatr Infect Dis J 1996;15:967-78.
7. 7 Nadel S, Britto J, Booy R, Maconochie I, Habibi P, Levin M. Avoidable deficiencies in the delivery of health care to children with meningococcal disease. J Accid Emerg Med 1998;15:298-303.
8. 8 Nadel S, Levin M, Habibi P. Treatment of meningococcal disease in childhood. In: Cartwright K, ed. Meningococcal disease. Chichester: John Wiley and Sons, 1995:207-43.
9. 9 Britto J, DeMunter C, Habibi P. Specialized pediatric inter-hospital transfer. In: Tibbrel D, Van der Voort E, eds. Intensive care in childhood. Berlin: Springer-Verlag, 1996:146-58.
10. 10 Levin M, Galassini R, de Munter C, et al. Improved survival in children admitted to intensive care with meningococcal disease. 2nd Annual Spring Meeting of the Royal College of Paediatrics and Child Health, University of York [abstract]. London: Royal College of Paediatrics and Child Health, 1998.
11. 11 Pollack MM, Alexander SR, Clarke N, Ruttimann UE, Tesselaar HM, Bachulis AC. Improved outcomes from tertiary center pediatric intensive care: a statewide comparison of tertiary and nontertiary care facilities [see comments]. Crit Care Med 1991;19:150-9.
12. 12 Marzouk O, Thomson AP, Sills JA, Hart CA, Harris F. Features and outcome in meningococcal disease presenting with maculopapular rash. Arch Dis Child 1991;66:485-7.
13. 13 Edwards MS, Baker CJ. Complications and sequelae of meningococcal infections in children. J Pediatr 1981;99: 540-5.
14. 14 Stiehm ER, Damrosch DS. Factors in the prognosis of meningococcal infection. Review of 63 cases with emphasis on recognition and management of the severely ill patient. J Pediatr 1966;68:457-67.
15. 15 Pollard AJ, DeMunter C, Nadel S, Levin M. Abandoning empirical antibiotics for febrile children. Lancet 1997;350: 811-12.
16. 16 Tobin JR, Wetzel RC. Shock and multiorgan failure. In: Rogers MC, ed. Textbook of pediatric intensive care. Baltimore: Williams and Wilkins, 1996:555-605.
17. 17 Mercier JC, Beaufils F, Hartmann JF, Azema D. Hemodynamic patterns of meningococcal shock in children. Crit Care Med 1988;16:27-33.
18. 18 Parrillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med 1993;328:1471-7.
19. 19 Parrillo JE, Burch C, Shelhamer JH, Parker MM, Natanson C, Schuette W. A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest 1985;76:1539-53.
20. 20 Carcillo JA, Davis AL, Zaritsky A. Role of early fluid resuscitation in pediatric septic shock. JAMA 1991;266:1242-5.
21. 21 Hodge DD. Intraosseous infusions: a review. Pediatr Emerg Care 1985;1:215-18.
22. 22 Dula DJ, Lutz P, Vogel MF, Weaver BN. Rapid flow rates for the resuscitation of hypovolemic shock. Ann Emerg Med 1985;14:303-6.
23. 23 Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ 1998;317: 235-40.
24. 24 Nadel S, De Munter C, Britto J, Levin M, Habibi P. Albumin: saint or sinner. Arch Dis Child 1998;79:384-5.
25. 25 Hussain SN, Roussos C. Distribution of respiratory muscle and organ blood flow during endotoxic shock in dogs. J Appl Physiol 1985;59:1802-8.
26. 26 Ledingham IM, McArdle CS. Prospective study of the treatment of septic shock. Lancet 1978;i:1194-7.
27. 27 Yamamoto LG, Yim GK, Britten AG. Rapid sequence anesthesia induction for emergency intubation. Pediatr Emerg Care 1990;6:200-13.
28. 28 Khilnani P. Electrolyte abnormalities in critically ill children. Crit Care Med 1992;20:241-50.
29. 29 Mauger DC. Hypokalaemia as a consistent feature of fulminant meningococcal septicaemia. Aust Paediatr J 1971;7: 84-6.
30. 30 Britto J, Nadel S, Habibi P, Levin M. Hypokalaemia in meningococcal disease [abstract]. Intensive Care Med 1996; 22 (suppl):S021.
31. 31 Gauthier B, Trachtman H, Di Carmine F, et al. Hypocalcemia and hypercalcitoninemia in critically ill children. Crit Care Med 1990;18:1215-19.
32. 32 Goldhill DR. Calcium and magnesium. Care of the Critically Ill 1997;13:112-15.
33. 33 Chernow B. Calcium: does it have a therapeutic role in sepsis? Crit Care Med 1990;18:895-6.
34. 34 Fuhrman BP. Hypocalcemia and critical illness in children. J Pediatr 1989;114:990-1.
35. 35 Zaloga GP, Washburn D, Black KW, Prielipp R. Human sepsis increases lymphocyte intracellular calcium. Crit Care Med 1993;21:196-202.
36. 36 Steinhorn DM, Sweeney MF, Layman LK. Pharmacodynamic response to ionized calcium during acute sepsis. Crit Care Med 1990;18:851-7.
37. 37 Whang R, Whang DD, Ryan MP. Refractory potassium repletion. A consequence of magnesium deficiency. Arch Intern Med 1992;152:40-5.
38. 38 Hamill-Ruth RJ, McGory R. Magnesium repletion and its effect on potassium homeostasis in critically ill adults: results of a double-blind, randomized, controlled trial. Crit Care Med 1996;24:38-45.
39. 39 Edwards R, Mitchell M, Twaddle S. Hypophosphataemia in the critically ill patient - aetiology and management. Care of the Critically Ill 1998;14:267-70.
40. 40 Weisinger JR, Bellorin-Font E. Magnesium and phosphorus. Lancet 1998;352:391-6.
41. 41 Odio CM, Faingezicht I, Paris M, et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med 1991; 324:1525-31.
42. 42 Rennick G, Shann F, de Campo J. Cerebral herniation during bacterial meningitis in children. BMJ 1993;306:953-5.
43. 43 Sarnaik AP, Lieh-Lai MW. Transporting the neurologically compromised child. Pediatr Clin North Am 1993;40: 337-54.
44. 44 Poss WB, Brockmeyer DL, Clay B, Dean JM. Pathophysiology and management of the intracranial vault. In: Rogers MC, ed. Textbook of pediatric intensive care. Baltimore: Williams and Wilkins, 1996:645-65.
45. 45 Duke T. Fluid management of bacterial meningitis in developing countries. Arch Dis Child 1998;79:181-5.
46. 46 Dezateux CA, Dinwiddie R, Helms P, Matthew DJ. Recognition and early management of Reye's syndrome. Arch Dis Child 1986;61:647-51.
47. 47 Anon. Relative contraindications to lumbar puncture. In: Group ALS, ed. Advanced paediatric life support - the practical approach. London: BMJ Publishing Group, 1997:27.
48. 48 Berkowitz ID, Berkowitz FE, Newton C, Willoughby R, Ackerman AD. Meningitis, Infectious encephalopathies and other central nervous sytem infections. In: Rogers MC, ed. Textbook of pediatric intensive care. Baltimore: Williams and Wilkins, 1996:1039-90.
49. 49 McIntyre PB, Berkey CS, King SM, et al. Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. JAMA 1997;278: 925-31.
50. 50 Morley SL, Levin M. Bacterial meningitis. Prescribers' Journal 1998;38:129-41.
51. 51 Schaad UB, Kaplan SL, McCracken GH Jr. Steroid therapy for bacterial meningitis. Clin Infect Dis 1995;20:685-90.
52. 52 Schaad UB, Lips U, Gnehm HE, Blumberg A, Heinzer I, Wedgwood J. Dexamethasone therapy for bacterial meningitis in children. Swiss Meningitis Study Group. Lancet 1993;342:457-61.
53. 53 Feigin RD, Pearlman E. Bacterial meningitis beyond the neonatal period. In: Feigin RD, Cherry JD, eds. Textbook of pediatric infectious diseases. 4th ed. Philadelphia: WB Saunders Company, 1998:400-29.
54. 54 Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987;317:653-8.
55. 55 Lefering R, Neugebauer EA. Steroid controversy in sepsis and septic shock: a meta-analysis. Crit Care Med 1995;23: 1294-303.
56. 56 Perkins MD, Mirrett S, Reller LB. Rapid bacterial antigen detection is not clinically useful. J Clin Microbiol 1995;33: 1486-91.
57. 57 Kaczmarski EB, Ragunathan PL, Marsh J, Gray SJ, Guiver M. Creating a national service for the diagnosis of meningococcal disease by polymerase chain reaction. Commun Dis Public Health 1998;1:54-6.
58. 58 Borrow R, Guiver M, Sadler F, Kaczmarski EB, Fox AJ. False positive diagnosis of meningococcal infection by the IS1106 PCR ELISA. FEMS Microbiol Lett 1998;162: 215-18.
59. 59 Cartwright K, Kroll S. Optimising the investigation of meningococcal disease. BMJ 1997;315:757-8.
60. 60 Anon. Control of meningococcal disease: guidance for consultants in communicable disease control. PHLS Meningococcal Infections Working Group and Public Health Medicine Environmental Group. Commun Dis Rep CDR Rev 1995;5(13):R189-95.